Estimation of usefulness of intravenous admnistration of alendoronate for bone disorders after gastrectomy
Phase 2
- Conditions
- Distrubances of bone tissue metabolism
- Registration Number
- JPRN-UMIN000012143
- Lead Sponsor
- Yokohama City University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with some diseaes which may be worse by the participation of this study. 2. Pregnant patients or patients who hope pregnancy 3. Patients who are judged inappropriate by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bone mineral density (L1-4)
- Secondary Outcome Measures
Name Time Method 1. Bone mineral density of the total hip 2. Bone turnover markers (serum BAP, serum NTx, Serum TPACP-5b) 3. Adverse effect